NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 56 min 16 sec ago

Emerging Infectious Diseases Research Centers - Coordination Center (U01 Clinical Trial Not Allowed)

Mon, 2019-03-04 07:53
Funding Opportunity RFA-AI-19-029 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for an Emerging Infectious Diseases Research Centers Coordination Center (EIDRC CC) for the Emerging Infectious Diseases Research Centers (EIDRC). The EIDRC CC will oversee and coordinate select aspects of each EIDRCs research project(s) involving data management, sample collection and storage, sharing of reagents, diagnostics, and resources, and will facilitate collaboration between the newly awarded EIDRCs, and other USG and international agencies, as appropriate.

Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)

Mon, 2019-03-04 02:14
Funding Opportunity PAR-19-207 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIAAA/NIDA R25 program is to support educational activities that foster a better understanding of biomedical, behavioral, and clinical research on alcohol and other substance use disorders and their implications. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Outreach. Specifically, this FOA will support projects designed to engage practicing health care professionals in education about current and emerging knowledge derived from scientific research on the neurobiology, epidemiology, prevention, and/or treatment of alcohol and other substance use disorders and related health conditions.

Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)

Mon, 2019-03-04 01:54
Funding Opportunity PAR-19-209 from the NIH Guide for Grants and Contracts. The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative on-demand, event -driven and long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy, and (HIV/STI) and non-HIV STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development and formulation science supported by animal model testing. Also supported are biobehavioral and behavioral/social studies to identify MPT user-desired rheological and biophysical factors (look, feel, effectiveness, safety and duration of action) and other behavioral/social factors that could promote increased MPT adoption and use.

Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations An ORWH FY19 Administrative Supplement (Admin Supp Clinical Trial Optional)

Fri, 2019-03-01 12:43
Funding Opportunity PA-19-205 from the NIH Guide for Grants and Contracts. The Office of Research on Women's Health (ORWH) announces the availability of administrative supplements to support interdisciplinary, transdisciplinary and multidisciplinary research focused on the effect of sex/gender influences at the intersection of several social determinants, including but not limited to: race/ethnicity, socioeconomic status, education, health literacy and other social determinants in human health and illness. This research includes preclinical, clinical, behavioral and translational studies with the specific purpose to provide Administrative Supplements to active NIH parent grants for one year to address health disparities among women of populations in the US who are understudied, underrepresented and underreported in biomedical research. The proposed research must address an area specified within Goal 1 and 2 of the new Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women". These goals focus on advancing rigorous research that is relevant to the health of women (Goal 1) and developing methods and leveraging data sources to consider sex and gender influences that enhance research for the health of women (Goal 2). Projects must include a focus on one or more NIH-designated health disparities populations, which include Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minorities (SGM). Combinations of one or more populations is also encouraged, e.g. socioeconomically disadvantaged sexual and gender minorities.

Request for Information (RFI) Seeking Stakeholder Input on the Need for an NIH Administrative Data Enclave

Fri, 2019-03-01 11:30
Notice NOT-OD-19-085 from the NIH Guide for Grants and Contracts

Limited Competition: Renewal of the Aging Interventions Testing Program (U01 Clinical Trial Not Allowed)

Fri, 2019-03-01 11:13
Funding Opportunity RFA-AG-19-030 from the NIH Guide for Grants and Contracts. The Aging Interventions Testing Program (ITP) tests, under standardized conditions, potential intervention strategies which may decelerate the rate of aging in mammals. The rate of aging is to be measured by lifespan extension and/or improvements in health at later ages due to the intervention. The ITP has used lifespan as its primary outcome for an intervention, with limited studies on end-of-life pathologies and selected tests of health across the lifespan (health span). This FOA calls for renewal of the ITP with the following goals: 1) Continue to test compounds for effects on lifespan; 2) Increase histology and pathophysiology analyses at time of death; 3) Increase focused studies of health span on selected compounds.

Interventions Testing Program Data Coordinating Center (U24 Clinical Trial Not Allowed)

Fri, 2019-03-01 11:13
Funding Opportunity RFA-AG-19-031 from the NIH Guide for Grants and Contracts. The Interventions Testing Program (ITP) tests, under standardized conditions, potential intervention strategies which may decelerate the rate of aging in mammals. The National Institute on Aging (NIA) invites applications specific to establishing a Data Coordinating Center (DCC) that will support storage and analysis of primary and secondary data obtained by the ITP. A public-access website and data repository will be maintained by this DCC to provide access to standard operating procedures and experimental outcomes.

Pages